HF
BHVN icon

HRT Financial’s Biohaven BHVN Stock Holding History

HRT Financial’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4M Sell
268,529
-565,137
-68% -$6.08M 0.01% 1281
2026
Q1 		$7.05M Buy
833,666
+164,530
+25% +$1.8M 0.02% 796
2025
Q4 		$7.55M Sell
669,136
-112,187
-14% -$1.39M 0.02% 570
2025
Q3 		$11.7M Buy
781,323
+748,011
+2,245% +$10.9M 0.04% 338
2025
Q2 		$470K Buy
33,312
+17,770
+114% +$317K ﹤0.01% 1635
2025
Q1 		$373K Buy
+15,542
New +$548K ﹤0.01% 1654
2023
Q3 		– Sell
-44,854
Closed -$1.07M – 2412
2023
Q2 		$1.07M Buy
+44,854
New +$772K 0.01% 913

Other funds holding BHVN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HRT Financial's BHVN Position: Q2 2026 in Review

HRT Financial reduced its Biohaven (BHVN) stake by 68% in Q2 2026, selling an estimated $6.08M and leaving 268,529 shares worth $4M. The position accounts for 0.01% of the portfolio, ranked #1281.

HRT Financial first reported a position in BHVN in Q2 2023 and has held it in 7 quarters since. The position peaked at $11.7M in Q3 2025. 296 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • HRT Financial held 268,529 shares of Biohaven worth $4M as of Q2 2026.
  • HRT Financial sold 565,137 Biohaven shares in Q2 2026, an estimated $6.08M.
  • Biohaven made up 0.01% of HRT Financial's portfolio in Q2 2026, its #1281 holding.
  • HRT Financial first reported a position in Biohaven in Q2 2023 and has held it in 7 quarters since.
  • HRT Financial's Biohaven position peaked at $11.7M in Q3 2025.
  • 296 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.